» Articles » PMID: 38776446

Parosmia Is Positively Associated With Problematic Drinking, As Is Phantosmia With Depressive Symptoms

Overview
Journal J Addict Med
Specialty Psychiatry
Date 2024 May 22
PMID 38776446
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Alcohol use disorder (AUD) is a global health problem with significant negative consequences, including preventable deaths. Although olfactory dysfunction is associated with chronic alcohol drinking, the relationship among specific types of olfactory deficits, depressive symptoms, and problematic drinking remains to be explored. Here, we examined the prevalence of olfactory distortion (parosmia) and hallucination (phantosmia) and assessed their associations with problematic drinking and depressive symptoms.

Methods: In April-June 2022, 250 participants across the spectrum of AUD were recruited for assessment in the National Institute on Alcohol Abuse and Alcoholism COVID-19 Pandemic Impact on Alcohol study. Surveys covered self-reported olfactory function, depressive symptoms, and problematic drinking, with key measures assessed, including the Alcohol Use Disorders Identification Test and the Patient Health Questionnaire. Predictors in the analysis included parosmia and phantosmia, with covariates comprising age, sex, socioeconomic status, race, ethnicity, COVID-19 infection status, and smoking status.

Results: Among 250 individuals, 5.2% experienced parosmia and 4.4% reported phantosmia. Parosmia was associated with higher Alcohol Use Disorders Identification Test scores (β = 7.14; 95% confidence interval = 3.31, 10.96; P < 0.001), whereas phantosmia was linked to higher Patient Health Questionnaire scores (β = 3.32; 95% confidence interval = 0.22, 6.42; P = 0.03). These associations persisted in both the full sample and the subset of participants without COVID-19.

Conclusions: Our study highlights strong existing links among olfactory deficits, problem drinking, and depressive symptoms, underscoring the need to assess smell impairments in clinical settings. Future research should explore these connections further to develop new treatments for individuals with AUD and depression.

References
1.
Iannilli E, Leopold D, Hornung D, Hummel T . Advances in Understanding Parosmia: An fMRI Study. ORL J Otorhinolaryngol Relat Spec. 2019; 81(4):185-192. DOI: 10.1159/000500558. View

2.
Schambeck S, Crowell C, Wagner K, DIppolito E, Burrell T, Mijocevic H . Phantosmia, Parosmia, and Dysgeusia Are Prolonged and Late-Onset Symptoms of COVID-19. J Clin Med. 2021; 10(22). PMC: 8618742. DOI: 10.3390/jcm10225266. View

3.
Hoffman H, Rawal S, Li C, Duffy V . New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunction. Rev Endocr Metab Disord. 2016; 17(2):221-40. PMC: 5033684. DOI: 10.1007/s11154-016-9364-1. View

4.
Rupp C, Fleischhacker W, Hausmann A, Mair D, Hinterhuber H, Kurz M . Olfactory functioning in patients with alcohol dependence: impairments in odor judgements. Alcohol Alcohol. 2004; 39(6):514-9. DOI: 10.1093/alcalc/agh100. View

5.
Kwako L, Schwandt M, Ramchandani V, Diazgranados N, Koob G, Volkow N . Neurofunctional Domains Derived From Deep Behavioral Phenotyping in Alcohol Use Disorder. Am J Psychiatry. 2019; 176(9):744-753. PMC: 6609498. DOI: 10.1176/appi.ajp.2018.18030357. View